Polina Sawyer, MD
Urogynecology and Reconstructive Pelvic Surgery · Peoria, AZNPI 1245657725
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,427 of the $4,482 with a category attached, or 76.5%. 16 manufacturers reported payments, led by Axonics, Inc. at 37.2% of the total. Reporting peaked in 2024 at $2,109 and has fallen 52.5% since, to $1,002 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in AZ, where the typical reported total is $8,817.
Across 143 payments — averaging $31.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Caldera Medical, Inc$965
- Coloplast$295
- AbbVie$253
- Medtronic$244
- Femselect Inc.$238
- plus $818 from 10 others
What the payments were for
- Travel & lodging$1,03523%
- Food & beverage$3,42776%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 18 | $1,668 |
| Caldera Medical, Inc | 71 | $965 |
| Coloplast | 7 | $295 |
| AbbVie | 14 | $253 |
| Medtronic(2 entities) | 6 | $244 |
| Femselect Inc. | 5 | $238 |
| Bluewind Medical | 3 | $186 |
| Medical Device Business Services, Inc. | 1 | $130 |
| Coopersurgical, Inc. | 1 | $119 |
| Boston Scientific | 6 | $118 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| 180 Medical, Inc. | 2 | $57 |
| Smith+Nephew | 3 | $57 |
| Baxter Healthcare | 1 | $41 |
| Convatec Inc. | 1 | $37 |
| Astellas Pharma US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,482 in reported general payments places this provider in the 20th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Arizona.
See all urogynecology and reconstructive pelvic surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 90 | $75,968 |
| MyrbetriqMirabegron | 82 | $58,625 |
| Estradiol | 170 | $10,975 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 167 | $2,061 |
| NitrofurantoinNitrofurantoin Macrocrystal | 31 | $1,745 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 169 | $353 |
| Ibuprofen | 69 | $272 |
| Fluconazole | 33 | $255 |
| Cephalexin | 22 | $241 |
| Clobetasol Propionate | 15 | $225 |
| Ciprofloxacin Hcl | 42 | $196 |
| Oxycodone Hcl | 52 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $59 | $75,96890 claims |
| Astellas Pharma US IncMyrbetriq | $16 | $58,62582 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Arizona.
Other urogynecology and reconstructive pelvic surgery in Peoria
- Ali AzadiPeoria$8K
- Suzette SutherlandScottsdale$354K
- Jennifer KlauschieLitchfield Park$95K
- Gina CliettOro Valley$76K
- Anthony GaddiGilbert$72K
- Felipe VidelaPhoenix$25K
- Kelly KantartzisMesa$21K
- Daniel StonePhoenix$20K
- Mohammad IslamScottsdale$19K
- Peter JeppsonMesa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.